About Acoustic Wave Cell Therapy
Acoustic Wave Cell Therapy is a private company based in Van Nuys, California. It has reported $20,509,883 raised in three offerings on Form D since May 2017. Its chief executive is Charles Engles.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 3, 2023 | Nov 13, 2023 | $10,426,093of $15.0M target | 17 | $613K | Equity, $388,062 in SAFE's which converted into Series C-1 Preferred Stock, C-2 Preferred Stock and Common Stock issuable upon conversion of the preferred stock.Rule 506(b) | Form D ↗ |
| Apr 17, 2018 | Feb 8, 2019 | $8,208,790fully sold | 29 | $283K | EquityRule 506(b) | Form D ↗ |
| Sep 6, 2016 | May 23, 2017 | $1,875,000fully sold | 5 | $375K | Equity, Securities on exercise, Series A Preferred, SAFE's with common stock issuable upon conversion thereof.Rule 506(b) | Form D ↗ |
| Total, three offerings | $20,509,883 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Acoustic Wave Cell Therapy's Form D filed Nov 13, 2023.
CE
Charles Engles
Chief Executive Officer and director
On every Form D that Acoustic Wave Cell Therapy has filed: 3 filings, from May 23, 2017 to Nov 13, 2023.
TL
Tom Lue
Director
On every Form D that Acoustic Wave Cell Therapy has filed: 3 filings, from May 23, 2017 to Nov 13, 2023.
CW
Chiahui Wang
Director
First appears on the Form D that Acoustic Wave Cell Therapy filed on November 13, 2023; on 1 of its 3 filings.
PM
Paul Maccaskill
Director
On every Form D that Acoustic Wave Cell Therapy has filed: 3 filings, from May 23, 2017 to Nov 13, 2023.